Missing/wrong data?
Log in to edit
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
scientific article published on 7 August 2013
Author/s
author: Nicholas Schwab, Tania Kümpfel, Bernd C Kieseier, Heinz Wiendl, Dorothea Buck, Ralf Gold, Brigitte Wildemann, Sven G Meuth, Christoph Kleinschnitz, Kerstin Göbel
Work details
Publication date
August 7, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.